Background This report presents a systematic review of scientific literature published between 1990–2010 relating to the frequency of human brucellosis, commissioned by WHO. The objectives were to identify high quality disease incidence data to complement existing knowledge of the global disease burden and, ultimately, to contribute towards the calculation of a Disability-Adjusted Life Years (DALY) estimate for brucellosis. Methods/Principal Findings Thirty three databases were searched, identifying 2,385 articles relating to human brucellosis. Based on strict screening criteria, 60 studies were selected for quality assessment, of which only 29 were of sufficient quality for data analysis. Data were only available from 15 countries in the regions of Northern Africa and Middle East, Western Europe, Central and South America, Sub-Saharan Africa, and Central Asia. Half of the studies presented incidence data, six of which were longitudinal prospective studies, and half presented seroprevalence data which were converted to incidence rates. Brucellosis incidence varied widely between, and within, countries. Although study biases cannot be ruled out, demographic, occupational, and socioeconomic factors likely play a role. Aggregated data at national or regional levels do not capture these complexities of disease dynamics and, consequently, at-risk populations or areas may be overlooked. In many brucellosis-endemic countries, health systems are weak and passively-acquired official data underestimate the true disease burden. Conclusions High quality research is essential for an accurate assessment of disease burden, particularly in Eastern Europe, the Asia-Pacific, Central and South America and Africa where data are lacking. Providing formal epidemiological and statistical training to researchers is essential for improving study quality. An integrated approach to disease surveillance involving both human health and veterinary services would allow a better understanding of disease dynamics at the animal-human interface, as well as a more cost-effective utilisation of resources.
References
[1]
Ariza J, Bosilkovski M, Cascio A, Colmenero J, Corbel M, et al. (2007) Prospectives for the Treatment of Brucellosis in the 21st Century: The Ioannina Recommendations. PLoS Medicine 4: e317. doi: 10.1371/journal.pmed.0040317
[2]
Corbel M (2006) Brucellosis in Humans and Animals: FAO, OIE, WHO. Available: http://www.who.int/csr/resources/publica？tions/Brucellosis.pdf. Accessed 2012 May 7.
[3]
Roth F, Zinsstag J, Orkhon D, Chimid-Ochir G, Hutton G, et al. (2003) Human health benefits from livestock vaccination for brucellosis: case study. Bulletin of the World Health Organization 81: 867–876.
[4]
Perry BR (2002) Ch. 7 - Animal disease impact on the poor: study results. Investing in Animal Research to Alleviate Poverty. Nairobi: International Livestock Research Institute. pp. 67–78.
[5]
World Health Organization (2006) The Control of Neglected Diseases: A route to poverty alleviation. Available: http://www.who.int/zoonoses/Report_Sept0？6.pdf. Accessed 2012 May 7
[6]
Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV (2006) The new global map of human brucellosis. Lancet Infect Dis 6: 91–99. doi: 10.1016/S1473-3099(06)70382-6
[7]
Bonfoh B, Kasymbekov J, Dürr S, Toktobaev N, Doherr M, et al. (2011) Representative Seroprevalences of Brucellosis in Humans and Livestock in Kyrgyzstan. Eco Health DOI: 10.1007/s10393-011-0722-x. doi: 10.1007/s10393-011-0722-x
[8]
Crump JA, Youssef FG, Luby SP, Wasfy MO, Rangel JM, et al. (2003) Estimating the incidence of typhoid fever and other febrile illnesses in developing countries. Emerg Infect Dis 9: 539–544. doi: 10.3201/eid0905.020428
[9]
Jennings GJ, Hajjeh RA, Girgis FY, Fadeel MA, Maksoud MA, et al. (2007) Brucellosis as a cause of acute febrile illness in Egypt. Trans R Soc Trop Med Hyg 101: 707–713. doi: 10.1016/j.trstmh.2007.02.027
[10]
Awad R (1998) Human brucellosis in the Gaza Strip, Palestine. East Mediterr Health J 4: 225–233.
[11]
Gargouri N, Walke H, Belbeisi A, Hadadin A, Salah S, et al. (2009) Estimated burden of human Salmonella, Shigella, and Brucella infections in Jordan, 2003–2004. Foodborne Pathog Dis 6: 481–486. doi: 10.1089/fpd.2008.0192
[12]
Avdikou I, Maipa V, Alamanos Y (2005) Epidemiology of human brucellosis in a defined area of Northwestern Greece. Epidemiol Infect 133: 905–910. doi: 10.1017/S0950268805003973
[13]
Minas M, Minas A, Gourgulianis K, Stournara A (2007) Epidemiological and clinical aspects of human brucellosis in Central Greece. Jpn J Infect Dis 60: 362–366.
[14]
Al Tawfiq JA, AbuKhamsin A (2009) A 24-year study of the epidemiology of human brucellosis in a health-care system in Eastern Saudi Arabia. J Infect Public Health 2: 81–85. doi: 10.1016/j.jiph.2009.03.003
[15]
Doyle TJ, Bryan RT (2000) Infectious disease morbidity in the US region bordering Mexico, 1990–1998. J Infect Dis 182: 1503–1510. doi: 10.1086/315876
[16]
Elbeltagy KE (2001) An epidemiological profile of brucellosis in Tabuk Province, Saudi Arabia. East Mediterr Health J 7: 791–798.
[17]
De Massis F, Di Girolamo A, Petrini A, Pizzigallo E, Giovannini A (2005) Correlation between animal and human brucellosis in Italy during the period 1997–2002. Clin Microbiol Infect 11: 632–636. doi: 10.1111/j.1469-0691.2005.01204.x
[18]
Haghdoost AA, Kawaguchi L, Mirzazadeh A, Rashidi H, Sarafinejad A, et al. (2007) Using GIS in explaining spatial distribution of brucellosis in an endemic district in Iran. Iran J Public Health 36: 27–34.
[19]
Abu Shaqra QM (2000) Epidemiological aspects of brucellosis in Jordan. Eur J Epidemiol 16: 581–584. doi: 10.1023/A:1007688925027
[20]
Jelastopulu E, Merekoulias G, Alexopoulos EC (2010) Underreporting of communicable diseases in the prefecture of Achaia, western Greece, 1999–2004-missed opportunities for early intervention. Eurosurveillance 15: 16–21.
[21]
Dahouk SA, Neubauer H, Hensel A, Schoneberg I, Nockler K, et al. (2007) Changing epidemiology of human brucellosis, Germany, 1962–2005. Emerg Infect Dis 13: 1895–1900. doi: 10.3201/eid1312.070527
[22]
El Sherbini A, Kabbash I, Schelling E, Shennawy S, Shalapy N, et al. (2007) Seroprevalences and local variation of human and livestock brucellosis in two villages in Gharbia Governorate, Egypt. Trans R Soc Trop Med Hyg 101: 923–928. doi: 10.1016/j.trstmh.2007.04.020
[23]
Karabay O, Serin E, Tamer A, Gokdogan F, Alpteker H, et al. (2004) Hepatitis B carriage and Brucella seroprevalence in urban and rural areas of Bolu province of Turkey: a prospective epidemiologic study. Turk J Gastroenterol 15: 11–13.
[24]
Cetinkaya Z, Aktepe OC, Ciftci IH, Demirel R (2005) Seroprevalence of human brucellosis in a rural area of Western Anatolia, Turkey. J Health PopulNutr 23: 137–141.
[25]
Yacoub A, Bakr S, Hameed AM, Al Thamery AA, Fartoci MJ (2006) Seroepidemiology of selected zoonotic infections in Basra region of Iraq. East Mediterr Health J 12: 112–118.
[26]
Al Sekait MA (1999) Seroepidemiology survey of brucellosis antibodies in Saudi Arabia. Ann Saudi Med 19: 219–222.
[27]
Alballa SR (1995) Epidemiology of human brucellosis in southern Saudi Arabia. J Trop Med Hyg 98: 185–189.
[28]
Vancelik S, Guraksin A, Ayyildiz A (2008) Seroprevalence of human brucellosis in rural endemic areas in eastern Turkey. Trop Doct 38: 42–43. doi: 10.1258/td.2007.060004
[29]
Marder G, Franco Sycz AE, Czernik GE, Dur n G (2005) Seroprevalencia de brucelosis en hemodonantes del Banco de Sangre de Corrientes, Argentina. Revista Veterinaria 16: 61–64.
Hernandez B, Garcia R, Cruz E, Rojo J (1999) Seroprevalencia de brucelosis en disponentes de sangre del Hospital General de M？xico. Rev Med Hosp Gen Mex 62: 107–112.
[32]
Al-Ani FK, El-Qaderi S, Hailat NQ, Razziq R, Al-Darraji AM (2004) Human and animal brucellosis in Jordan between 1996 and 1998: a study. Rev Sci Tech 23: 831–840.
[33]
Schelling E, Diguimbaye C, Daoud S, Nicolet J, Boerlin P, et al. (2003) Brucellosis and Q-fever seroprevalences of nomadic pastoralists and their livestock in Chad. Prev Vet Med 61: 279–293. doi: 10.1016/j.prevetmed.2003.08.004
[34]
Alavi SM, Rafiei A, Nikkhooi A (2007) The effect of lifestyle on brucellosis among nomads in Khuzestan province of Iran. Pak J Med Sci 23: 358–360.
[35]
Idris MA, Maiwald M, el-Mauly KN, Ruppel A (1993) Human brucellosis in Dhofar, Sultanate of Oman. J Trop Med Hyg 96: 46–50.
[36]
Hosseini MR, Sadeghi M, Khondabi E, Bakhshali H, Jamal-Omidi A (2008) Incidence of Brucellosis in Shazand County, Iran, 2006. Int J Infect Dis 12: E446–E447.
[37]
European Food Safety Authority, European Centre for Disease Prevention and Control (2009) The European Union Summary Report on Trends and Sources of Zoonoses,Zoonotic Agents and Food-borne Outbreaks in 2009. EFSA Journal 9: 2090.
[38]
Zinsstag J, Schelling E, Bonfoh B, Fooks A, Kasymbekov J, et al. (2009) Towards a “One Health” research and application tool box. Veterinaria Italiana 45: 121–133.
[39]
Zinsstag J, Schelling E, Wyss K, Bechir M (2005) Potential of cooperation between human and animal health to strengthen health systems. Lancet 366: 2142–2145. doi: 10.1016/S0140-6736(05)67731-8
[40]
STROBE Statement. Available: http://www.strobe-statement.org/. Accessed 2012 May 7.
